The U.S. Food and Drug Administration on Thursday gave full approval to the Alzheimer’s drug Leqembi, clearing the way for insurance coverage of the pricey drug. “The full FDA approval will open the floodgates for people with early Alzheimer’s to get this drug. It’s a big deal because it’s very expensive at $26,500 per year,”… read on > read on >
Add risk of developing memory problems later in life to the list of consequences linked to poor oral health. Not taking care of your mouth and teeth has already been associated with heart disease, diabetes, certain cancers and preterm birth. Now, a new study finds that folks with gum disease or tooth loss have evidence… read on > read on >
Loneliness might be a true heartbreaker for people with diabetes — raising their odds of a heart attack even more than unhealthy lifestyle habits do. That’s according to a new study of over 18,000 adults with the blood sugar disease. Researchers found that people who reported feeling lonely were up to 26% more likely to… read on > read on >
THURSDAY, July 6, 2023 (American Heart Association News) — As a psychotherapist and wellness consultant with clients from New York to New Zealand, Aishia Grevenberg is happy to recommend self-care. But don’t expect it to end in a day at the spa. “I think ‘self-care’ is a truly watered-down term, in the sense that it… read on > read on >
Could swings in your blood fat levels increase your chances of being diagnosed with Alzheimer’s disease? Yes, suggests a new study that found fluctuating cholesterol levels among older adults may increase the risk for Alzheimer’s disease and other dementias. Those who had the most fluctuations in cholesterol had a 19% higher risk of developing Alzheimer’s… read on > read on >
Stimulant medications like Ritalin are commonly prescribed to help treat the symptoms of attention deficit hyperactivity disorder, but there have been concerns the drugs may lay the groundwork for later substance abuse. New research may now set those worries at ease. Children who take prescription stimulants for ADHD do not have more substance use disorders… read on > read on >
A lot of experts advise getting a good night’s sleep. For Black Americans who have a gene variant linked to Alzheimer’s disease, that rest could be protective, a new study says. “This new finding suggests that someone with a high-risk variant might be able to overcome their genetic inheritance by improving their sleep habits,” said… read on > read on >
When frail patients go into cardiac arrest and need cardiopulmonary resuscitation (CPR) during surgery, they’re more likely to die than those who are stronger, a new study shows. Researchers from Brigham and Women’s Hospital in Boston studied the impact of frailty on survival in these cases where previously frailty was not considered as a factor.… read on > read on >
Decades of “redlining” — discriminatory policies that led to disinvestment in minority communities within the United States — may be connected with current cases of kidney failure in Black adults. A new study from researchers at Boston University School of Public Health (BUSPH) shows that long-term disinvestment of wealth and resources in historically redlined neighborhoods… read on > read on >
New research finds that Medicaid expansion under the Affordable Care Act — also known as Obamacare — brought an unexpected benefit: increases in how many patients got palliative care. “Our findings are encouraging, especially with growing evidence of the important benefits of palliative care for patients with cancer,” said lead study author Dr. Xuesong Han,… read on > read on >
-300x173.jpg)
